Market Cap | ₹63,507Cr |
ROE | 10.68% |
P/E Ratio(TTM) | 18.73 |
EPS(TTM) | 57.88 |
P/B Ratio | 1.94 |
Dividend Yield | 0.00% |
Industry P/E | 33.85 |
Book Value | 557.29 |
Debt to Equity | 0.25 |
Face Value | 1 |
Parent Organisation | Aurobindo Pharma Limited |
Managing Director | Mr. K. Nityananda Reddy |
NSE Symbol | AUROPHARMA |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Sun Pharmaceutical Industries | NA (0.00%) | 36.89 | ||
Cipla | NA (0.00%) | 22.49 | ||
Dr Reddy's Laboratories | NA (0.00%) | 17.98 | ||
Mankind Pharma | NA (0.00%) | 53.14 |